Bixin loaded solid lipid nanoparticles for enhanced hepatoprotection - Preparation, characterisation and in vivo evaluation

International Journal of Pharmaceutics

Volumn 473, Issue 1-2, 2014, Pages 485-492

  Rao, Madipatla Prathyusha ^a   Manjunath, Kopparam ^a   Bhagawati, Siddalingappa Tippanna ^a,b   Thippeswami, Boreddy Shivanandappa ^a  

^a SREE SIDDAGANGA COLLEGE OF PHARMACY   (India)

^b MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Bixin; DSC; FTIR; Hepatoprotection; SEM; Solid lipid nanoparticles

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; BIXIN; BUFFER; GLUTATHIONE; GLYCEROL STEARATE; LIPID; MALONALDEHYDE; PARACETAMOL; PHOSPHATIDYLCHOLINE; SOLID LIPID NANOPARTICLE; STABILIZING AGENT; TRIMYRISTIN; UNCLASSIFIED DRUG; ACYLGLYCEROL; CAROTENOID; DRUG CARRIER; NANOPARTICLE; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIPID PEROXIDATION; LIVER PROTECTION; LIVER TOXICITY; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; RAT; SOYBEAN; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; ANIMAL; BLOOD; CHEMISTRY; DRUG FORMULATION; DRUG-INDUCED LIVER INJURY; LIVER; METABOLISM; PATHOLOGY; WISTAR RAT;

ACETAMINOPHEN; ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CAROTENOIDS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG-INDUCED LIVER INJURY; GLUTATHIONE; GLYCERIDES; LECITHINS; LIPID PEROXIDATION; LIVER; NANOPARTICLES; RATS, WISTAR; TRIGLYCERIDES;

EID: 84905492678     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.07.027     Document Type: Article

References (21)

1. R. Ahsan, K.M. Islam, A. Musaddik, and E. Haque Hepatoprotective activity of methanol extract of some medicinal plants against carbon tetra-chloride-induced hepatotoxicity in rats Global J. Pharmacol. 3 2009 116 122
2. D.W. Bradley, J.E. Maynard, G.E. Emery, and H. Webster Stability of certain drugs of abuse in urine specimens Clin. Chem. 18 1972 1442
3. B. Chengaiah, K.M. Rao, K.K. Mahesh, M. Alasundaram, and C.M. Chetty Medicinal importance of natural dyes a review Int. J. Pharm. Tech. Res. 2 2010 144 154
4. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
5. D. Gelvan, and P. Saltman Different cellular targets for Cu- and Fe-catalyzed oxidation observed using a Cu-compatible thiobarbituric acid assay Biochim. Biophys. Acta 1035 1990 353 360 (Pubitemid 20277156)
6. V. Jenning, A.F. Thunemann, and S.H. Gohla Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids Int. J. Pharm. 199 2000 167 177 (Pubitemid 30236188)
7. L. Jin-juan, Y. Guang-de, W. Hong-Ying, and Z. San-qi Preparation and liver targeting of floxuridinyl dibutyrate Acta Pharm. Sin. 43 2008 761 765
8. L.G. Luna Manual of Histology and Staining Methods of Armed Forces Institute of Pathology third ed. 1986 McGraw Hill Book Co. New York 1 31
9. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177 (Pubitemid 30326695)
10. V. Nayak, T.B. Gincy, M. Prakash, C. Joshi, S.S. Rao, S.N. Somayaji, N.V. Madhav, and K.L. Bairy Hepatoprotective activity of aloe vera gel against paracetamol induced hepatotoxicity in albino rats Asian J. Pharm. Biol. Res. 2 2011 94 98
11. R. Rej, C.F. Fasce, and R.E. Vanderlinde Increased aspartate aminotransferase activity of serum after in vitro supplementation with pyridoxal phosphate Clin. Chem. 19 1973 92
12. M.A. Schubert, and C.C. Muller-Goymann Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and non-ionic emulsifier Eur. J. Pharm. Biopharm. 61 2005 77 86 (Pubitemid 41096691)
13. C.R. Silva, L.M.G. Antunes, and L.P. Md Bianchi Antioxidant action of bixin against cisplatin induced chromosome aberrations and lipid peroxidation in rats Pharmacol. Res. 43 2001 561 566 (Pubitemid 32619993)
14. G. Suresh, K. Manjunath, V. Venkateswarlu, and V. Satyanarayana Preparation characterization and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles AAPS PharmSciTech 8 2007 24
15. N.W. Tietz Text Book of Clinical Chemistry 1986 W.B. Saunders Philadelphia 57
16. S. Vasu, V. Palaniyappan, H.P. Kothandam, and S. Badami Micro wave facilitated extraction of bixin from Bixa orellana L. and its in vitro antioxidant activity Der Pharm. Lett. 2 2010 479 485
17. J. Wang, X. Sun, and Z. Zhang Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5′-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticles Eur. J. Pharm. Biopharm. 54 2002 285 290 (Pubitemid 35341828)
18. Z. Xu, L. Chen, W. Gu, Y. Gao, L. Lin, Z. Zhang, Y. Xi, and Y. Li The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma Biomaterials 30 2009 226 232
19. P. Yang, Y.U. Lian, H.U. Yan-qiu, M.A. Li-na, C.A.O. Yue-sheng, Z. Lei, M. Mitsuhiko, Y. Junko, and Y. Saburo Study on targeting and in vitro anti-oxidation of baicalin solid lipid nanoparticles Chin. Herb. Med. 4 2012 335 339
20. Drug Delivery Nanoparticles Formulation and Characterization first ed. P. Yashwant, and T. Deepak Drugs and the Pharmaceutical Sciences vol. 191 2009 CRC Press Boca Raton, Florida
21. B.T. Yu, X. Sun, and Z.R. Zhang Enhanced liver targeting by synthesis of N1-stearyl-5-Fu and incorporation into solid lipid nanoparticles Arch. Pharm. Res. 26 2004 1096 1101